Interventional oncology is a branch of medical science that deals with minimally invasive medical procedures carried out under image guidance by interventional radiologists for the diagnosis, treatment, and palliation of different types of cancer.
Interventional Oncology: Introduction
- Interventional oncology is a branch of medical science that deals with minimally invasive medical procedures carried out under image guidance by interventional radiologists for the diagnosis, treatment, and palliation of different types of cancer
- In interventional oncology procedures, different image guided techniques such as computed tomography, fluoroscopy, and ultrasound are used to diagnose and treat the specific site affected with pain or cancer
- The interventional oncology procedure is most commonly performed with other cancer treatments such as surgery, chemotherapy, and radiation therapy. These procedures offer several advantages such as quicker recover, shorter hospital stays, minimal side-effects, and more precise and accurate treatment as compared to other therapeutic procedures.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=60477
Key Drivers of Global Interventional Oncology Market
- The global interventional oncology market is primarily driven by high prevalence and increase in incidence rates of cancer worldwide. Cancer is a leading cause of death globally, after cardiovascular diseases.
- According to the World Health Organization (WHO), cancer accounts for 8.3 million deaths each year, with 70% new cancer cases expected to be reported over the next 20 years. Rise in cancer afflicted population is anticipated to be a key driver of the market.
- According to a Centers for Disease Control and Prevention (CDC) report, in 2014, the number of cancer patients diagnosed in the U.S. reached approximately 21 million. This number is expected to reach 25.4 million by the end of 2024. Moreover, advantages of minimally invasive surgical procedures, technological advancements in interventional oncology, increased government funding for oncology procedures, etc., are estimated to fuel the interventional oncology market during the forecast period.
Request for Analysis of COVID-19 Impact on Interventional Oncology Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=60477
Embolization Procedure to be Highly Attractive Segment
- In terms of procedure, the global interventional oncology market can be classified into ablation procedure, embolization procedure, and radiotherapy procedure
- Embolization procedure is highly preferred across the globe due to benefits associated with the procedure, followed by the ablation procedure. Embolization is a process involving lodging of embolus within the bloodstream in order to block the blood supply to the tumor. The process involves chemical or irradiation technique for selective occlusion of blood vessels by introducing emboli. Radiotherapy is a treatment for cancer and other less common diseases such as thyroid, blood disorders, and even to restrict noncancerous cell growth. Radiotherapy is an extensively utilized technique in interventional oncology. Radiotherapy procedure involves radiation through light or heat energy. The embolization segment is projected to hold a significant market share and expand at a rapid CAGR during the forecast period.
Pre book Interventional Oncology Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=60477<ype=S
Laser Therapy to be Highly Attractive Segment
- Based on indication, the global interventional oncology market can be categorized into lung cancer, renal cancer, osteosarcoma, hepatocellular carcinoma, splenomegaly, intrahepatic cholangiocarcinoma, neuroendocrine tumor, glioblastoma multiforme, metastatic colorectal cancer, and others
- The lung cancer segment is estimated to account for a prominent share of the market during the forecast period owing to the high prevalence of lung cancer
Hospitals to be Highly Lucrative Segment
- Based on end-user, the global interventional oncology market can be categorized into hospitals, clinics, and ambulatory surgical centers
- The hospitals segment is likely to account for a major share of the global Interventional Oncology market by 2031 due to an increase in consultation of patients in hospitals
Top of FormRead More Information:
https://www.transparencymarketresearch.com/interventional-oncology-market.html
Key Players Operating in Global Interventional Oncology Market
The global interventional oncology market is semi-consolidated, with the presence of international and local players. Key players operating in the global interventional oncology market are:
- Boston Scientific Corporation, Medtronic plc
- Terumo Corporation
- BTG plc.
- AngioDynamics, Inc.
- Ethicon, Inc. (Johnson & Johnson)
- Merit Medical Systems, Inc.
- Sirtex Medical Limited
- Siemens Healthineers
- Eckert & Ziegler BEBIG
- Varian Medical Systems, Inc.
- HealthTronics, Inc.
Browse More Market Reports:
AI-based Medical Diagnostic Tools Market:
Across the globe, expanding predominance of way of lifestyle ailments alongside immense patient populace has suggestively upgraded the development of artificial intelligence in the medical sector. New FDA regulations of AI frameworks alongside improved and coordinated calculations, and promising pipeline gadgets in the medical diagnostics sector are key aspects driving the general development of global AI-based medical diagnostic tools market.
Increasing awareness about minimally invasive treatments, progress in bioengineering technologies, and expanding base of aging population are the factors that are triggering the growth of global bioimplants market. For example, a large chunk of the elderly population requires dental implants for restorative care thereby fuelling the need for dental bioimplants. Besides, various lifestyle-related chronic diseases such as rheumatoid arthritis, cardiovascular diseases, and metabolic disorders have skyrocketed the requirement for bioimplants globally.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453